华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02563 华昊中天医药-B

停牌 04-17 09:21:05

4.410

+0.000

0.00%

最高4.410	最低4.410	成交量0.00
今开4.410	昨收4.410	日振幅0.00%
总市值16.08亿	流通市值9.56亿	总股本3.65亿
成交额0.00	换手率0.00%	流通股本2.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"华昊中天医药-B","latestPrice":4.41,"timestamp":1744852865773,"preClose":4.41,"halted":3,"volume":0,"delay":0,"floatShares":216720857,"shares":364588000,"eps":-0.5760985803566576,"marketStatus":"停牌","change":0,"latestTime":"04-17 09:21:05","open":4.41,"high":4.41,"low":4.41,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.5760985803566576,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1730304000000,"exchange":"SEHK","adjPreClose":4.41,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":1.0694108154509598,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02563","defaultTab":"news","newsList":[{"id":"2518210397","title":"华昊中天医药-B03月10日主力净流出15万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518210397?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:16","pubTimestamp":1741594570,"startTime":"0","endTime":"0","summary":"03月10日, 华昊中天医药-B股价跌19.04%，报收12.50元，成交金额363万元，换手率0.13%，振幅15.03%，量比2.78。华昊中天医药-B今日主力资金净流出15万元，上一交易日主力净流出0万元。该股近5个交易日下跌22.26%，主力资金累计净流出15万元；近20日主力资金累计净流入249万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170118a269ba8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170118a269ba8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","BK1574","02563"],"gpt_icon":0},{"id":"2514029968","title":"华昊中天医药-B获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029968","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514029968?lang=zh_cn&edition=full","pubTime":"2025-02-26 08:20","pubTimestamp":1740529200,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华昊中天医药-B（02563）发布公告，根据恒生指数有限公司于2025年2月21日宣布的指数检讨结果，公司已获恒生指数有限公司选定并将纳入恒生综合指数成份股。该变动将于2025年3月7日收市后实施并于2025年3月10日起生效。\n　　董事会认为，获纳入恒生综合指数反映资本市场对公司业务表现及价值的高度认可，将有助扩大股东基础并增加其股份交易的流通性，从而提高公司于资本市场的投资价值及声誉。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-26/doc-inemuerm3863117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1574","159938","02563","BK1161","09939","HSCI"],"gpt_icon":0},{"id":"2514094708","title":"【华昊中天医药-B(02563.HK)发盈警，预期年度净亏损1.46亿元至约1.51亿元】华昊中天医药-B(02563.HK)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514094708","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514094708?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:56","pubTimestamp":1740491793,"startTime":"0","endTime":"0","summary":"华昊中天医药-B(02563.HK)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25215648383396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02563","09939","159938","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2514109423","title":"华昊中天医药-B(02563)发盈警，预期年度净亏损1.46亿元至约1.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514109423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514109423?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:46","pubTimestamp":1740491197,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布公告，本集团预期截至2024年度将录得净亏损介乎约人民币1.46亿元至约人民币1.51亿元，而截至2023年12月31日止年度本集团则录得净亏损约人民币1.896亿元。董事会认为，上述亏损减少主要得益于产品市场渗透提高导致销售收入增长、产品生产工艺优化所带来的销售成本降低以及严格控制销售开支所带来的销售费用减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02563","09939","159938","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2514098970","title":"华昊中天医药撤回两笔投资款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2514098970","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514098970?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:57","pubTimestamp":1740484646,"startTime":"0","endTime":"0","summary":"2月25日，华昊中天医药-B发布公告，指出公司于2024年11月22日和11月25日分别认购了两家不同基金公司的保本低风险基金产品，投资金额为3800万元和2200万元。公告日期时，公司已将这两笔认购全部撤回并收回了全部款项。公司高层在综合评估后认为，这些投资的条款公平合理，符合公司的整体利益。公司强调这是无心之失，并表示已全数收回投资款项，未来不会影响首次公开发售所得款项的正常使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225195809962fcc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225195809962fcc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","BK1574","02563"],"gpt_icon":0},{"id":"2513266263","title":"华昊中天医药-B(02563)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2513266263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513266263?lang=zh_cn&edition=full","pubTime":"2025-02-21 19:18","pubTimestamp":1740136715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月21日，恒生指数公司公布最新季检结果，其中华昊中天医药-B获纳入恒生综合指数成份股，所有变动将于2025年3月7日(星期五)收市后实施并于2025年3月10日(星期一)起生效。据中信证券研报估算，中华昊中天医药-B有可能被纳入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02563","09939","YANG","BK1515","HSCI","BK1574","HSTECH","159938","HSCEI","BK1161"],"gpt_icon":0},{"id":"2509323951","title":"华昊中天医药(02563.HK)优替德隆胶囊II/ III期临床研究获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2509323951","media":"阿斯达克财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509323951?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:45","pubTimestamp":1738773900,"startTime":"0","endTime":"0","summary":"华昊中天医药－Ｂ(02563.HK) 公布，集团的重要海外管线之一，优替德隆胶囊“UTD2”联合卡培他滨和奥沙利铂一线治疗PD -L1阴性的局部晚期或转移性胃或胃食管交界处腺癌的国际多中心II/ III期注册临床研究“BG 02 -2404”已获美国食品药品管理局“FDA”批准。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241023093229939_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241023093229939_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1415083/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1515","BK1161","BK1574","02563","09939"],"gpt_icon":0},{"id":"2509280605","title":"华昊中天医药-B(02563)：美国食品药品管理局批准优替德隆胶囊一线治疗晚期胃癌II/III期国际多中心临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280605","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509280605?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:59","pubTimestamp":1738767552,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B 发布公告，本集团的重要海外管线之一，优替德隆胶囊联合卡培他滨和奥沙利铂一线治疗PD-L1阴性的局部晚期或转移性胃或胃食管交界处腺癌的国际多中心II/III期注册临床研究已获得美国食品药品管理局的批准。UTD2也因此获得了FDA授予的治疗晚期胃癌孤儿药资格认定。BG02-2404是本公司针对UTD2开展的首个国际多中心II/III期注册临床研究，旨在进一步夯实本公司国际化开发战略的实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1246312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK1515","BK1161","09939","III","02563","BK1574","159938"],"gpt_icon":0},{"id":"2505050752","title":"华昊中天医药－Ｂ(02563)股价上升5.076%，现价港币$16.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2505050752","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505050752?lang=zh_cn&edition=full","pubTime":"2025-01-22 10:55","pubTimestamp":1737514500,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在上午10:55比前收市价上升5.076%，现股价为港币$16.56。至目前为止，今日最高价为$16.56，而最低价为$16.1。总成交量为1.18万股，总成交金额为港币$19.232万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501222039/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02563","BK1574","09939","159938","BK1161","BK1515"],"gpt_icon":0},{"id":"2504344883","title":"华昊中天医药－Ｂ(02563)股价上升7.351%，现价港币$15.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2504344883","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504344883?lang=zh_cn&edition=full","pubTime":"2025-01-20 09:40","pubTimestamp":1737337200,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在上午09:40比前收市价上升7.351%，现股价为港币$15.48。至目前为止，今日最高价为$15.48，而最低价为$15.0。总成交量为1400股，总成交金额为港币$2.119万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501201211/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","159938","02563","BK1515","09939"],"gpt_icon":0},{"id":"2503655418","title":"华昊中天医药－Ｂ(02563)股价上升5.68%，现价港币$14.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2503655418","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503655418?lang=zh_cn&edition=full","pubTime":"2025-01-15 10:14","pubTimestamp":1736907240,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在上午10:14比前收市价上升5.68%，现股价为港币$14.14。至目前为止，今日最高价为$14.14，而最低价为$13.4。总成交量为3800股，总成交金额为港币$5.166万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR250115282/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02563","09939","BK1515","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"2500376971","title":"华昊中天医药－Ｂ(02563)股价大幅波动15.052%，现价港币$16.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2500376971","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500376971?lang=zh_cn&edition=full","pubTime":"2025-01-03 11:35","pubTimestamp":1735875300,"startTime":"0","endTime":"0","summary":"[异动股]华昊中天医药－Ｂ(02563) 股价在上午11:35出现大幅波动15.052%，现股价为港币$16.8，比前收市价上升9.948%。至目前为止，今日最高价为$16.8，而最低价为$14.5。总成交量为3.56万股，总成交金额为港币$54.709万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC25010364/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02563","BK1574","159938","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2500213767","title":"华昊中天医药－Ｂ(02563)股价上升9.948%，现价港币$16.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2500213767","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500213767?lang=zh_cn&edition=full","pubTime":"2025-01-03 11:35","pubTimestamp":1735875300,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在上午11:35比前收市价上升9.948%，现股价为港币$16.8。至目前为止，今日最高价为$16.8，而最低价为$14.5。总成交量为3.56万股，总成交金额为港币$54.709万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501032782/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1161","02563","159938","09939","BK1574"],"gpt_icon":0},{"id":"2500992037","title":"瑞恩资本：24年香港新上市公司共71家  募资875亿港元 金额同比增加88.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500992037","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500992037?lang=zh_cn&edition=full","pubTime":"2025-01-02 14:07","pubTimestamp":1735798059,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今日，瑞恩资本发文称，2024年香港新上市公司共 71家，募资874.78亿，新上市数量较上年同期减少2家，募资金额同比增加411.57亿或 88.85%。另外，截至2024年12月31日，停牌时间超过3个月以上的上市公司共66家，占上市公司总数量的2.51%。今年通过IPO上市的 70家上市公司一共募资874.78亿，较2023年的463.21亿增加411.57亿或88.85%，主要原因是超大型IPO美的集团募资高达356.66亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0502904849.HKD","06681","06979","LU1961090484.USD","600988","02562","600276","02533","LU0979878070.USD","02477","02571","300750","399300","02432","LU0823414478.USD","02545","02613","603906","LU2348773727.SGD","02410","BK0239","LU0348805143.USD","LU0543330483.HKD","02550","688506","LU0651946864.USD","00805","02560","EVS.SI","LU0505663152.USD","603288","02509","LU1023057109.AUD","159982","002352","02519","00300","02596","002803","LU1880383366.USD","BK0175","02563","BK0187","02497","02551","002865","02530"],"gpt_icon":1},{"id":"2495910786","title":"“合成生物学第一股”两个交易日跌回发行价 成功上市2个月，华昊中天医药业绩何时“上岸”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2495910786","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495910786?lang=zh_cn&edition=full","pubTime":"2024-12-31 20:32","pubTimestamp":1735648333,"startTime":"0","endTime":"0","summary":"12月31日，《每日经济新闻》记者拨打华昊中天医药公开电话，截至发稿未获接听。针对指定产品的年度终端销售额，华昊中天医药将按梯度向百洋智合支付推广服务费。资料显示，百洋医药旗下的百洋健康是华昊中天医药港股IPO时引入的4位基石投资者之一，前者认购金额为200万美元。截至今年5月31日，华昊中天医药的现金及现金等价物为3592.7万元，较上年同期锐减71.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231203306a2107245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231203306a2107245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1515","09939","02563"],"gpt_icon":0},{"id":"2495542350","title":"维持2个月涨势后，单日最大跌幅逾40%的华昊中天医药-B(02563)的背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2495542350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495542350?lang=zh_cn&edition=full","pubTime":"2024-12-30 21:23","pubTimestamp":1735565007,"startTime":"0","endTime":"0","summary":"自今天10月31日首挂上市以来，华昊中天医药-B股价一路稳步走高。然而在12月17日，华昊中天医药收盘拉出一条长上影线后，却开启了其上市以来的首个下跌之旅。没有量能上的支持，12月24日华昊中天医药变盘迹象开始明显。不过将时间拉长至近20日，华昊中天医药卖方席位前两位则分别是海盈证券和富途证券，分别卖出170.28万股和16.6万股。而目前来看，单日暴跌逾40%的华昊中天医药似乎也未能摆脱股价下跌的命运。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1231263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02563","09939","159938","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2495968594","title":"华昊中天医药－Ｂ(02563)股价大幅下跌42.631%，现价港币$18.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2495968594","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495968594?lang=zh_cn&edition=full","pubTime":"2024-12-30 15:29","pubTimestamp":1735543740,"startTime":"0","endTime":"0","summary":"[下跌股]华昊中天医药－Ｂ(02563) 股价在下午03:29比前收市价大幅下跌42.631%，现股价为港币$18.1。至目前为止，今日最高价为$31.05，而最低价为$18.1。总成交量为57.86万股，总成交金额为港币$1.309千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2412301173/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1161","02563","09939","159938","BK1574"],"gpt_icon":0},{"id":"2495596473","title":"港股异动 | 华昊中天医药-B(02563)暴跌超37% 抹去上市以来全部涨幅 市值缩水至72亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495596473","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495596473?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:53","pubTimestamp":1735541634,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华昊中天医药-B暴跌超37%，该股于今年10月31日挂牌上市，当日即收涨30%，此后股价稳步攀升。截至发稿，跌37.18%，报19.82港元，成交额1194.71万港元。据悉，华昊中天成立于2002年，是一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药。业绩方面，华昊中天至今并未实现盈利，公司2022年、2023年营收分别为3282万元、6664万元，期内亏损分别为1.61亿元、1.9亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02563","BK1574","BK1161","09939","159938","BK1515"],"gpt_icon":0},{"id":"2491653755","title":"华昊中天医药－Ｂ(02563)股价上升8.48%，现价港币$33.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2491653755","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491653755?lang=zh_cn&edition=full","pubTime":"2024-12-16 15:20","pubTimestamp":1734333600,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在下午03:20比前收市价上升8.48%，现股价为港币$33.9。至目前为止，今日最高价为$33.9，而最低价为$30.9。总成交量为35.88万股，总成交金额为港币$1.142千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412161008/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1574","BK1515","09939","02563","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biostar-pharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.5642},{"period":"3month","weight":-0.6942},{"period":"6month","weight":-0.7244},{"period":"ytd","weight":-0.7761}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京华昊中天生物医药股份有限公司是一家主要从事创新药研发、生产及销售的中国公司。该公司的产品及管线主要包括优替德隆注射液、优替德隆胶囊、优替德隆纳米剂型、优替德隆抗体偶联药物（ADC）、BG22、BG18和BG44。该公司的产品主要用于治疗复发或转移性乳腺癌、人类表皮生长因子受体2（HER2）阴性乳腺癌新辅助治疗、晚期非小细胞肺癌（NSCLC）、实体瘤、乳腺癌脑转移、肺癌脑转移等脑部肿瘤适应症。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"华昊中天医药-B","nameEN":"BIOSTAR PHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华昊中天医药-B,02563,华昊中天医药-B股票,华昊中天医药-B股票老虎,华昊中天医药-B股票老虎国际,华昊中天医药-B行情,华昊中天医药-B股票行情,华昊中天医药-B股价,华昊中天医药-B股市,华昊中天医药-B股票价格,华昊中天医药-B股票交易,华昊中天医药-B股票购买,华昊中天医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}